type 2 diabetes
Conditions
Interventions
Intervention Group:Nusulin 2.0g orally each time, 3 times a day
Control Group:Placebo, with the same dose of that of the Intervention Group
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with physician diagnosed type 2 diabetes and uncontrolled blood glucose (HbA1c>7.0% in those under 65 years, >7.5% in those 65 years or older); Aged 18-80 years Male or female; Have signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Participating in other clinical trials; 2. With known history of allergy to contents of Nusulin; 3. Having serious diseases of heart, lung, liver, kidney, brain or uncured cancer, or having serious psychiatric disease; 4. Having diabetic ketoacidosis or serious infections within 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c%; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood sugar;SF36 Quality of Life Score; | — |
Countries
China
Contacts
Public ContactWu Haiyun
Chinese PLA General Hospital
Outcome results
None listed